(Q38937694)

English

Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

7 September 2017

Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome (English)

1 reference

stated in

Europe PubMed Central

7 September 2017

3

Suzanne D Vernon

1 reference

stated in

Europe PubMed Central

7 September 2017

5

Michael Houghton

1 reference

stated in

Europe PubMed Central

7 September 2017

Abdolamir Landi

1

1 reference

stated in

Europe PubMed Central

PubMed ID

26615570

retrieved

7 September 2017

David Broadhurst

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

26615570

retrieved

7 September 2017

D Lorne J Tyrrell

series ordinal

4

1 reference

stated in

Europe PubMed Central

7 September 2017

23 November 2015

1 reference

stated in

Europe PubMed Central

7 September 2017

1 reference

Europe PubMed Central

7 September 2017

78

1 reference

stated in

Europe PubMed Central

7 September 2017

27-36

1 reference

stated in

Europe PubMed Central

7 September 2017

VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

IL-16 is differentially expressed in the developing human fetal brain by microglial cells in zones of neuropoesis.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Role of adaptive and innate immune cells in chronic fatigue syndrome/myalgic encephalomyelitis

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Cognitive impairments associated with CFS and POTS.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

A direct approach to false discovery rates

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Coordinated interaction of neurogenesis and angiogenesis in the adult songbird brain.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Senescent B lymphopoiesis is balanced in suppressive homeostasis: decrease in interleukin-7 and transforming growth factor-beta levels in stromal cells of senescence-accelerated mice.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Screening NK-, B- and T-cell phenotype and function in patients suffering from Chronic Fatigue Syndrome

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Antiangiogenic VEGF-A in peripheral artery disease

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Cytokine control of memory T-cell development and survival

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Interleukin 7 is produced by human intestinal epithelial cells and regulates the proliferation of intestinal mucosal lymphocytes

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Virology. A new virus for old diseases?

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Fit-for-purpose method development and validation for successful biomarker measurement.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Chronic fatigue syndrome: the need for subtypes

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Hepatic interleukin-7 expression regulates T cell responses

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Factors that may impact on immunosenescence: an appraisal

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

A neuro-immune model of Myalgic Encephalomyelitis/Chronic fatigue syndrome

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Signal transduction and regulation in smooth muscle

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Definitions and aetiology of myalgic encephalomyelitis: how the Canadian consensus clinical definition of myalgic encephalomyelitis works

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Plasma cytokines in women with chronic fatigue syndrome

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Statistical strategies for avoiding false discoveries in metabolomics and related experiments

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Recombinant origin of the retrovirus XMRV.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Cytokines across the night in chronic fatigue syndrome with and without fibromyalgia

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Decreased Expression of VEGF-A in Rat Experimental Autoimmune Encephalomyelitis and in Cerebrospinal Fluid Mononuclear Cells from Patients with Multiple Sclerosis

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Improving the diagnostic criteria and procedures for chronic fatigue syndrome

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Reversible modulations of neuronal plasticity by VEGF.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Vascular endothelial growth factor promotes proliferation of cortical neuron precursors by regulating E2F expression

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Central nervous system rather than immune cell-derived BDNF mediates axonal protective effects early in autoimmune demyelination

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Unintended Consequences of not Specifying Exclusionary Illnesses for Systemic Exertion Intolerance Disease

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

A formal analysis of cytokine networks in chronic fatigue syndrome

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Molecular quantitation of thymic output in mice and the effect of IL-7.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

VEGF reverts the cognitive impairment induced by a focal traumatic brain injury during the development of rats raised under environmental enrichment

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Distinct plasma immune signatures in ME/CFS are present early in the course of illness

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Il-7 and not stem cell factor reverses both the increase in apoptosis and the decline in thymopoiesis seen in aged mice.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

No association found between the detection of either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus and chronic fatigue syndrome in a blinded, multi-site, prospective study by the establishment and use of the Solv

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Failure to confirm XMRV/MLVs in the blood of patients with chronic fatigue syndrome: a multi-laboratory study

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Interleukin-7: from bench to clinic

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Increased blood-brain barrier permeability and endothelial abnormalities induced by vascular endothelial growth factor.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Production of IL-16 correlates with CD4+ Th1 inflammation and phosphorylation of axonal cytoskeleton in multiple sclerosis lesions

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

The critical role of VEGF in skeletal muscle angiogenesis and blood flow

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Interleukin-16 (IL-16) inhibits human immunodeficiency virus replication in cells from infected subjects, and serum IL-16 levels drop with disease progression

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

No evidence of murine-like gammaretroviruses in CFS patients previously identified as XMRV-infected

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Replication of an empirical approach to delineate the heterogeneity of chronic unexplained fatigue.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Interleukin-7 is trophic for embryonic neurons and is expressed in developing brain.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Age-associated thymic atrophy is linked to a decline in IL-7 production

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Chronic fatigue syndrome and circulating cytokines: A systematic review

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

VEGF links hippocampal activity with neurogenesis, learning and memory

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Cytokine and other immunologic markers in chronic fatigue syndrome and their relation to neuropsychological factors

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

VEGF significantly restores impaired memory behavior in Alzheimer's mice by improvement of vascular survival

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Immunosenescence of ageing

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

The expression of VEGF-A is down regulated in peripheral blood mononuclear cells of patients with secondary progressive multiple sclerosis

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Differential serum levels of eosinophilic eotaxins in primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

VEGF: a surrogate marker for peripheral vascular disease

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Human mid-gestation amniotic fluid contains interleukin-16 bioactivity.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Neuroinflammation in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: An ¹¹C-(R)-PK11195 PET Study.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

No evidence for XMRV nucleic acids, infectious virus or anti-XMRV antibodies in Canadian patients with chronic fatigue syndrome

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Cytokine expression provides clues to the pathophysiology of Gulf War illness and myalgic encephalomyelitis

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Cytokines in the cerebrospinal fluids of patients with chronic fatigue syndrome/myalgic encephalomyelitis

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CYTO.2015.11.018

Identifiers

DOI

10.1016/J.CYTO.2015.11.018

1 reference

stated in

Europe PubMed Central

7 September 2017

1 reference

Europe PubMed Central

PubMed ID

26615570

retrieved

7 September 2017

ResearchGate publication ID

285045223

0 references

(Q38937694)

Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)